Aprogen Medicines Inc. (KRX:007460)

Market Cap	116.84B -46.5%
Revenue (ttm)	117.97B -21.4%
Net Income	-70.20B
EPS	-3,540.00
Shares Out	20.57M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,778,219
Average Volume	1,627,837
Open	7,100.00
Previous Close	6,760.00
Day's Range	5,620.00 - 7,800.00
52-Week Range	5,210.00 - 210,944.55
Beta	0.11
RSI	54.44
Earnings Date	May 20, 2026

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 2000
• Employees: 256
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 007460

Financial Performance

In 2025, Aprogen Medicines's revenue was 117.97 billion, a decrease of -21.41% compared to the previous year's 150.11 billion. Losses were -70.20 billion, 20.9% more than in 2024.